Retrospective real-world com- parison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia. Curr Med Res Opin 2010;26(12):2861-2869.Wu EQ, Guerin A, Yu AP, Bollu VK, Guo A, Griffin JD. Retrospective real-world comparison of medical visits, ...
The recent American Society of Hematology (ASH) annual meeting, held in Orlando, Florida, in December 2019 was an exciting meeting for researchers and clinicians working in the field of chronic myeloid leukemia (CML), as well as for patients suffering from the disease. Interesting updates were ...
Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly (>43 year). However, the sequential occu... M Payandeh,E Sadeghi,R Khodarahmi,... - International Journal of Hematology-Oncology and Stem Cell Research 被引量: 3发表: 2014年...
The Content of Elements in Rainwater and Its Relation to the Frequency of Hospitalization for Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia in Opole Voivodship, Poland, During 2000–2002 Abstract Environmental factors play an essential role in the etiology of diseases of the hematopoietic sy...
BACKGROUND AND OBJECTIVE: Previous studies have shown that long-term outcomes are more favorable for patients newly diagnosed with chronic myeloid leukemia (CML) if a complete cytogenetic response is achieved within ≤12months of diagnosis. Because continuous and adequate dosing is important to achieve...
Table1. CH was defined as participants with any mCA and/or any somatic driver mutation; myeloid CH was defined as the presence of myeloid mCA and/or a myeloid somatic driver mutation(s); lymphoid was defined by lymphoid mCA and/or lymphoid mutations, without myeloid mutations or myeloid mCA...
Wong O, Harris F, Armstrong TW, Hu F (2010) A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Chem Biol Interact 184: 129–146. Supplementary Information accompanies this paper...
Acute myeloid leukemia CDC: Complement-dependent cytotoxicity CLL: Chronic lymphocytic leukemia CXCL12: C-X-C motif chemokine ligand 12 CXCR4: C-X-C chemokine receptor type 4 F-ara-A: Fludarabine PCD: Programmed cell death ROS: Reactive oxygen species SICD: Specific induced cell dea...
Imatinib has had an impressive impact on the management of chronic myeloid leukemia (CML) patients, with the majority achieving durable complete cytogenetic responses, and, at present, tyrosine kinase inhibitor therapy is expected to be life-long. As a result of this dramatic change in the prognos...
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia ArticleOpen access29 October 2021 Common and rare variant associations with clonal haematopoiesis phenotypes Article30 November 2022 Introduction Chronic lymphocytic leukaemia (CLL) is an indolent B-cell malignancy that has...